Clinical trials market is anticipated to grow at a significant CAGR of 5.3% during the forecast period. The key factors contributing to the market growth include increasing advancement in products by the addition of various technologies in a product such as new software, system to monitor clinical trials that take fewer times and attributed to the demand for the various new technologies and growing and also adoption is increasing that in turn contributing in the positive growth of the market. For instance, in May 2020, Royal Philips launched Clinical Trial Accelerator on Philips HealthSuite which allows life science organizations to integrate, analyze and store clinical and patient-reported data and also assist in faster decision-making. In addition, in December 2019, Teckro launched new software to streamline clinical trials, which uses machine-learning technology to transform clinical trial protocols from static documents into actionable data. This software provides feedback to improve performance, software additions can accelerate the speed and precision and also gives study administrators a consistent way to communicate.
Get Free Sample link @ https://www.omrglobal.com/request-sample/clinical-trials-market
The global clinical trials market is segmented based on the phase, study design, therapeutic area, and sponsor outlook. Based on this the market is segmented into phase I, phase II, phase III, and phase IV. Based on the study design, the market is segmented into interventional, observational, and expanded access. Based on the therapeutic area, the market is segmented into autoimmune disease, oncology, cardiology, infectious disease, dermatology, ophthalmology, and others. Based on the sponsor outlook, the market is subdivided into pharmaceutical & biopharmaceutical companies, medical device companies, and others. Among study design, the interventional segment is anticipated to hold a prominent share in the market owing to it is the most widely used method in clinical trials, this method is an improved way of measuring the efficacy of new intermediation, and also several advantages such as information on exposure are gained before disease develops among others are such factors that are driving segmental growth further in the market.
full report of Clinical Trials Market available @ https://www.omrglobal.com/industry-reports/clinical-trials-market
- Market Coverage
- Market number available for – 2022-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered- By Source, By Product Type, By Applications
- Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill
- , and others
Market Segmentation
Global Clinical Trials Market by Phase
- Phase I
- Phase II
- Phase III
- Phase IV
Global Clinical Trials Market by Study Design
- Interventional
- Observational
- Expanded Access
Global Clinical Trials Market by Therapeutic Area
- Autoimmune Disease
- Oncology
- Cardiology
- Infectious Disease
- Dermatology
- Ophthalmology
- Others (Women’s Health, Genetic Diseases, and Immunology)
Global Clinical Trials Market by Sponsor Outlook
- Pharmaceutical & Biopharmaceutical Companies
- Medical Device Companies
- Others (Academic Medical Centers, Industry-Sponsored)
Regional Analysis
- North America
- US
- Canada
- Europe
- UK
- Germany
- Italy
- Spain
- France
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Rest of the World
Company Profiles
- AccuLab Life Sciences
- BioAgile Therapeutics Pvt Ltd.
- Celerion
- Clario
- Dove Quality Solutions Ltd.
- Firma Clinical Research (Firma)
- Frontage Laboratories, Inc.
- Geneticist Inc
- ICON plc
- IQVIA
- Linical Americas
- Medpace, Inc.
- Novo Nordisk A/S
- Novotech
- Parexel International GmbH
- Pepgra
- PSI CRO AG
- SGS
- Syneos Health
- Thermo Fisher Scientific
The Report Covers
- Market value data analysis of 2021 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global clinical trials market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/clinical-trials-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
